Colossal Biosciences, founded by Ben Lamm, is pursuing the revival of extinct species such as the woolly mammoth, dodo, and thylacine, emphasizing a commitment to a successful and positive outcome. With substantial funding of $200 million and lab locations in Dallas, Cambridge, and Melbourne, the company plans to bring a woolly mammoth calf to life by late 2028. Lamm's vision includes using artificial wombs to protect endangered species, aiming for immediate successes with smaller mammals like mice within just two years. Contrasting cinematic depictions, Lamm champions a scientific and ecological approach to de-extinction.
Reviving extinct species like the woolly mammoth will contribute to biodiversity and provide valuable insights into genetics and ecosystem dynamics, while protecting currently endangered species.
Our aim is to create a positive narrative around de-extinction that wholly diverges from Hollywood portrayals, focusing instead on ecological benefits and long-term species preservation.
Collection
[
|
...
]